Mesenchymal stem cells transplantation in the treatment of tendon disorders
DOI:
https://doi.org/10.12775/QS.2025.37.57719Keywords
Mesenchymal Stem Cells, tendon injuries, tendon rupture, stem cellsAbstract
Introduction and purpose:
Tendon disorders are conditions that lead to pain, reduced mobility, and are often associated with recurrences and complications. A novel therapeutic approach for these conditions is the transplantation of mesenchymal stem cells (MSCs) into the affected area. This paper presents knowledge on the use of MSCs for the treatment of tendon disorders. Additionally, it presents advances in research regarding the application of MSC transplantation in the following conditions: rotator cuff tendon injuries, lateral epicondylitis, Achilles tendon disorders, and patellar tendon injuries.
Material and methods:
A review of the PubMed and Google Scholar databases was conducted.
Results:
It is suggested that MSCs support tendon regeneration through the regulation of inflammatory processes, their capacity to differentiate into various cell types, their influence on collagen synthesis, and their effect on the migration and proliferation of tenocytes. Research indicates that transplantation into damaged tendons enhances tendon function and reduces pain. While many studies have not reported the occurrence of side effects, some have noted such cases.
Conclusions:
Further research is required to develop a deeper understanding of the role that MSCs play in the treatment of tendon disorders. Additionally, there is a need to establish precise treatment protocols and evaluate the safety of this procedure.
References
1. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019;8(8):886. doi:10.3390/cells8080886
2. Chatterjee M, Muljadi PM, Andarawis-Puri N. The role of the tendon ECM in mechanotransduction: disruption and repair following overuse. Connect Tissue Res. 2022;63(1):28-42. doi:10.1080/03008207.2021.1925663
3. Haines JF. Bilateral rupture of the Achilles tendon in patients on steroid therapy. Ann Rheum Dis. 1983;42(6):652-654.
4. Magnan B, Bondi M, Pierantoni S, Samaila E. The pathogenesis of Achilles tendinopathy: A systematic review. Foot Ankle Surg. 2014;20(3):154-159. doi:10.1016/j.fas.2014.02.010
5. Butler DL, Juncosa N, Dressler MR. Functional efficacy of tendon repair processes. Annu Rev Biomed Eng. 2004;6:303-329. doi:10.1146/annurev.bioeng.6.040803.140240
6. Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clin Sports Med. 2003;22(4):675-692. doi:10.1016/s0278-5919(03)00004-8
7. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatol Oxf Engl. 2006;45(5):508-521. doi:10.1093/rheumatology/kel046
8. Nichols AEC, Best KT, Loiselle AE. The Cellular Basis of Fibrotic Tendon Healing: Challenges and Opportunities. Transl Res J Lab Clin Med. 2019;209:156-168. doi:10.1016/j.trsl.2019.02.002
9. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191. doi:10.1042/BSR20150025
10. Adolfsson E, Helenius G, Friberg Ö, Samano N, Frøbert O, Johansson K. Bone marrow- and adipose tissue-derived mesenchymal stem cells from donors with coronary artery disease; growth, yield, gene expression and the effect of oxygen concentration. Scand J Clin Lab Invest. 2020;80(4):318-326. doi:10.1080/00365513.2020.1741023
11. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal CCS. 2011;9:12. doi:10.1186/1478-811X-9-12
12. Doğan A. Embryonic Stem Cells in Development and Regenerative Medicine. Adv Exp Med Biol. 2018;1079:1-15. doi:10.1007/5584_2018_175
13. Lui PPY. Stem cell technology for tendon regeneration: current status, challenges, and future research directions. Stem Cells Cloning Adv Appl. 2015;8:163-174. doi:10.2147/SCCAA.S60832
14. Cha J, Park S, Lee SB. Induced Pluripotent Stem Cells: Next Generation Stem Cells to Clinical Applications.
15. Miyawaki S, Okada Y, Okano H, Miura K. Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells. Bio-Protoc. 2017;7(16):e2518. doi:10.21769/BioProtoc.2518
16. Filomeno P, Dayan V, Touriño C. Stem cell research and clinical development in tendon repair. Muscles Ligaments Tendons J. 2012;2(3):204-211.
17. Mao XF, Zhang XQ, Yao ZY, Mao HJ. Advances in mesenchymal stem cells therapy for tendinopathies. Chin J Traumatol. 2024;27(1):11-17. doi:10.1016/j.cjtee.2023.11.002
18. Xia T, Fu S, Yang R, et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases. J Inflamm. 2023;20(1):33. doi:10.1186/s12950-023-00360-z
19. Costa-Almeida R, Calejo I, Gomes ME. Mesenchymal Stem Cells Empowering Tendon Regenerative Therapies. Int J Mol Sci. 2019;20(12):3002. doi:10.3390/ijms20123002
20. Chen Y, Shao JZ, Xiang LX, Dong XJ, Zhang GR. Mesenchymal stem cells: A promising candidate in regenerative medicine. Int J Biochem Cell Biol. 2008;40(5):815-820. doi:10.1016/j.biocel.2008.01.007
21. Lee SY, Kwon B, Lee K, Son YH, Chung SG. Therapeutic Mechanisms of Human Adipose-Derived Mesenchymal Stem Cells in a Rat Tendon Injury Model. Am J Sports Med. 2017;45(6):1429-1439. doi:10.1177/0363546517689874
22. Jiang L, Lu J, Chen Y, et al. Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review). Int J Mol Med. 2023;52(2):70. doi:10.3892/ijmm.2023.5273
23. Barboni B, Russo V, Gatta V, et al. Therapeutic potential of hAECs for early Achilles tendon defect repair through regeneration. J Tissue Eng Regen Med. 2018;12(3):e1594-e1608. doi:10.1002/term.2584
24. Koch DW, Schnabel LV, Ellis IM, Bates RE, Berglund AK. TGF-β2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing. Stem Cell Res Ther. 2022;13(1):477. doi:10.1186/s13287-022-03172-9
25. Lamas JR, García-Fernández C, Tornero-Esteban P, et al. Adverse effects of xenogenic scaffolding in the context of a randomized double-blind placebo-controlled study for repairing full-thickness rotator cuff tears. Trials. 2019;20(1):387. doi:10.1186/s13063-019-3504-3
26. Jo CH, Chai JW, Jeong EC, et al. Intratendinous Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Rotator Cuff Disease: A First-In-Human Trial. Stem Cells Dayt Ohio. 2018;36(9):1441-1450. doi:10.1002/stem.2855
27. Jo CH, Chai JW, Jeong EC, Oh S, Yoon KS. Intratendinous Injection of Mesenchymal Stem Cells for the Treatment of Rotator Cuff Disease: A 2-Year Follow-Up Study. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2020;36(4):971-980. doi:10.1016/j.arthro.2019.11.120
28. Hernigou P, Flouzat Lachaniette CH, Delambre J, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38(9):1811-1818. doi:10.1007/s00264-014-2391-1
29. Chun SW, Kim W, Lee SY, et al. A randomized controlled trial of stem cell injection for tendon tear. Sci Rep. 2022;12(1):818. doi:10.1038/s41598-021-04656-z
30. Hurd JL, Facile TR, Weiss J, et al. Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective, randomized, controlled first-in-human pilot study. J Orthop Surg. 2020;15(1):122. doi:10.1186/s13018-020-01631-8
31. Centeno C, Fausel Z, Stemper I, Azuike U, Dodson E. A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis. Stem Cells Int. 2020;2020:5962354. doi:10.1155/2020/5962354
32. Lee SY, Kim W, Lim C, Chung SG. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells Dayt Ohio. 2015;33(10):2995-3005. doi:10.1002/stem.2110
33. Singh A, Gangwar DS, Singh S. Bone marrow injection: A novel treatment for tennis elbow. J Nat Sci Biol Med. 2014;5(2):389-391. doi:10.4103/0976-9668.136198
34. Khoury M, Tabben M, Rolón AU, Levi L, Chamari K, D’Hooghe P. Promising improvement of chronic lateral elbow tendinopathy by using adipose derived mesenchymal stromal cells: a pilot study. J Exp Orthop. 2021;8:6. doi:10.1186/s40634-020-00320-z
35. Goldberg AJ, Masci L, O’Donnell P, et al. Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy. Sci Rep. 2024;14(1):11421. doi:10.1038/s41598-024-61399-3
36. Thueakthong W, de Cesar Netto C, Garnjanagoonchorn A, et al. Outcomes of iliac crest bone marrow aspirate injection for the treatment of recalcitrant Achilles tendinopathy. Int Orthop. 2021;45(9):2423-2428. doi:10.1007/s00264-021-05112-3
37. Stein BE, Stroh DA, Schon LC. Outcomes of acute Achilles tendon rupture repair with bone marrow aspirate concentrate augmentation. Int Orthop. 2015;39(5):901-905. doi:10.1007/s00264-015-2725-7
38. Usuelli FG. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports Traumatol Arthrosc.
39. Arnaud-Franco Á, Lara-Arias J, Marino-Martínez IA, Cienfuegos-Jiménez O, Barbosa-Quintana Á, Peña-Martínez VM. Effect of Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Application in Achilles-Tendon Injury in an Animal Model. Curr Issues Mol Biol. 2022;44(12):5827-5838. doi:10.3390/cimb44120396
40. Pascual-Garrido C, Rolón A, Makino A. Treatment of Chronic Patellar Tendinopathy with Autologous Bone Marrow Stem Cells: A 5-Year-Followup. Stem Cells Int. 2012;2012:953510. doi:10.1155/2012/953510
41. Rodas G, Soler-Rich R, Rius-Tarruella J, et al. Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study. Am J Sports Med. 2021;49(6):1492-1504. doi:10.1177/0363546521998725
42. Soler R, Rodas G, Rius-Tarruella J, et al. Safety and Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Patellar Tendinopathy (With Gap >3 mm) in Patients: 12-Month Follow-up Results of a Phase 1/2 Clinical Trial. Orthop J Sports Med. 2023;11(9):23259671231184400. doi:10.1177/23259671231184400
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adrian Różycki, Michał Pniak, Paweł Miklis, Maciej Mawlichanów, Aleksandra Ciesielska, Aleksandra Sieradzka , Krzysztof Szerej, Alicja Kot, Marta Wojtczak, Natalia Myśliwiec
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 153
Number of citations: 0
